Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 23;9(6):ofac076.
doi: 10.1093/ofid/ofac076. eCollection 2022 Jun.

Nationwide Implementation of Nonpharmaceutical Interventions During the Coronavirus Disease 2019 Pandemic Is Associated With Decreased Incidence of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients

Affiliations

Nationwide Implementation of Nonpharmaceutical Interventions During the Coronavirus Disease 2019 Pandemic Is Associated With Decreased Incidence of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients

Keun Hyung Park et al. Open Forum Infect Dis. .

Abstract

This study aimed to investigate the impact of nationwide nonpharmaceutical interventions against coronavirus disease 2019 (COVID-19) on the incidence of Pneumocystis jirovecii pneumonia (PCP) in kidney transplant recipients. The monthly incidence of PCP during the COVID-19 period decreased significantly compared to that of the pre-COVID-19 period in kidney transplant recipients.

Keywords: COVID-19; Pneumocystis jirovecii pneumonia; kidney transplant recipients; nonpharmaceutical interventions.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Trends of monthly Pneumocystis jirovecii pneumonia (PCP) incidence. Regression models were adjusted for age, sex, number of hospitalizations, seasonality, type of immunosuppressive agent, and days after kidney transplantation.

References

    1. Neff RT, Jindal RM, Yoo DY, Hurst FP, Agodoa LY, Abbott KC.. Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia. Transplantation 2009; 88:135–41. - PubMed
    1. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19, 11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-genera.... Accessed 27 September 2021.
    1. Sung AD, Sung JAM, Thomas S, et al. . Universal mask usage for reduction of respiratory viral infections after stem cell transplant: a prospective trial. Clin Infect Dis 2016; 63:999–1006. - PMC - PubMed
    1. Abbas S, Raybould JE, Sastry S, de la Cruz O.. Respiratory viruses in transplant recipients: more than just a cold. Clinical syndromes and infection prevention principles. Int J Infect Dis 2017; 62:86–93. - PubMed
    1. Baker RE, Park SW, Yang W, Vecchi GA, Metcalf CJE, Grenfell BT.. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci U S A 2020; 117:30547–53. - PMC - PubMed

LinkOut - more resources